AI-generated summary
In this randomized, triple-blind, sham-controlled trial of 60 ICU patients, the authors report that daily photobiomodulation with red and near-infrared LEDs was associated with a shorter ICU length of stay and improved mobility, muscle strength and handgrip measures compared with sham. The authors conclude the results suggest benefit, though the abstract does not describe long-term outcomes.
- Participants
- 60
- Who or what was studied
- Adult patients admitted to a hospital intensive care unit
- Wavelengths
- 635, 880 nm
- Limits stated in the abstract
- The abstract does not describe long-term follow-up or detail how the sham condition was blinded beyond stating the trial was triple-blind.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 635 nm, 880 nm
- Power
- 1.2 mW, 15 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Sham, Photobiomodulation, Near-infrared. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.